Franco Cuccurullo

Author PubWeight™ 70.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005 5.07
2 Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005 4.19
3 The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003 2.14
4 Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009 1.59
5 Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke 2004 1.57
6 Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis. Am J Hypertens 2010 1.49
7 Epicardial adipose tissue and metabolic syndrome in hypertensive patients with normal body weight and waist circumference. Am J Hypertens 2011 1.48
8 Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens 2008 1.45
9 A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004 1.40
10 Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2010 1.39
11 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol 2006 1.38
12 Retracted Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 2004 1.22
13 Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens 2008 1.17
14 Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension. Am J Hypertens 2004 1.16
15 Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol 2005 1.15
16 Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. Clin Cancer Res 2012 1.15
17 A prospective evaluation of iron deficiency anemia in the GI endoscopy setting: role of standard endoscopy, videocapsule endoscopy, and CT-enteroclysis. Gastrointest Endosc 2011 1.11
18 PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. J Pathol 2006 1.11
19 Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation 2002 1.09
20 Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 2005 1.09
21 Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood 2011 1.07
22 Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin Cancer Res 2005 1.03
23 Blood pressure variability and cardiovascular risk in treated hypertensive patients. Am J Hypertens 2006 1.02
24 Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. Am J Cardiol 2012 1.00
25 Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 2004 0.97
26 Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications. PLoS One 2012 0.96
27 Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003 0.96
28 Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation 2003 0.95
29 Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 2006 0.92
30 Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002 0.91
31 Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk. Am J Hypertens 2007 0.91
32 Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radic Biol Med 2006 0.90
33 Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2010 0.89
34 Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev 2012 0.88
35 Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese women. Atherosclerosis 2004 0.87
36 Endothelial function in sustained and white coat hypertension. Am J Hypertens 2002 0.86
37 Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol 2002 0.85
38 Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. Am J Gastroenterol 2005 0.85
39 Circulating leptin is associated with oxidized LDL in postmenopausal women. Atherosclerosis 2004 0.84
40 Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin. Am J Hypertens 2002 0.84
41 Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension. Am J Hypertens 2004 0.83
42 Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs. Oncol Rep 2008 0.82
43 Obesity, poor muscle strength, and venous thromboembolism in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2010 0.82
44 Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. Anticancer Res 2007 0.82
45 Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness. Heart Vessels 2012 0.81
46 Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin. J Am Coll Cardiol 2002 0.81
47 Blood pressure variability and prognosis in uncomplicated mild hypertension. Am Heart J 2005 0.81
48 Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol 2004 0.81
49 Morning blood pressure surge, dipping, and risk of ischemic stroke in elderly patients treated for hypertension. Am J Hypertens 2013 0.81
50 Dihydrolipoic acid inhibits 15-lipoxygenase-dependent lipid peroxidation. Free Radic Biol Med 2003 0.80
51 Ambulatory blood pressure monitoring in type 2 diabetes and metabolic syndrome: a review. Blood Press Monit 2010 0.80
52 Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients. Atherosclerosis 2002 0.80
53 Risk of atrial fibrillation in dipper and nondipper sustained hypertensive patients. Blood Press Monit 2008 0.79
54 Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. Cancer Biol Ther 2005 0.79
55 New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia. Pathophysiol Haemost Thromb 2003 0.79
56 Aortic glutathione metabolic status: time-dependent alterations in fat-fed rabbits. Atherosclerosis 2004 0.79
57 Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation. Biochim Biophys Acta 2008 0.78
58 Helminthic infection as a factor in new-onset coffee allergy in a father and daughter. J Allergy Clin Immunol 2007 0.78
59 Vanadyl as a catalyst of human lipoprotein oxidation. Biochem Pharmacol 2002 0.78
60 Bicarbonate-dependent, carbonate radical anion-driven tocopherol-mediated human LDL peroxidation: an in vitro and in vivo study. Free Radic Res 2012 0.77
61 Masked hypertension in treated hypertensive patients. Am J Hypertens 2006 0.77
62 Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. Circulation 2003 0.77
63 Pravastatin up-regulates transforming growth factor-beta1 in THP-1 human macrophages: effect on scavenger receptor class A expression. Biochem Biophys Res Commun 2004 0.76
64 Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses. Thromb Res 2009 0.76
65 Arterial thrombosis in ambulatory cancer patients treated with chemotherapy. Thromb Res 2010 0.75
66 Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. Thromb Haemost 2007 0.75
67 Heart rate in hypertensive patients treated with ACE inhibitors and long-acting dihydropyridine calcium antagonists. J Cardiovasc Pharmacol 2002 0.75
68 Copper, zinc superoxide dismutase plus hydrogen peroxide: a catalytic system for human lipoprotein oxidation. FEBS Lett 2005 0.75
69 Myocardial glutathione metabolic status in fat-fed rabbits. Mol Cell Biochem 2014 0.75
70 Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. Blood Press Monit 2006 0.75
71 Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation. Biochem Pharmacol 2007 0.75
72 Transmural distribution of iron in the hypoxic and reoxygenated rabbit left ventricular myocardium. Biometals 2004 0.75
73 Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples. J Thromb Thrombolysis 2003 0.75
74 Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques. Clin Biochem 2010 0.75
75 Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy: meta-analysis of randomized trials. Am J Hypertens 2012 0.75